Search Results

There are 14521 results for: content related to: Hepatic Encephalopathy: Treatment

  1. Rifaximin for the Treatment of Hepatic Encephalopathy

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 28, Issue 8, August 2008, Pages: 1019–1032, Dr. Kenneth R. Lawrence and Dr. Jacqueline A. Klee

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.28.8.1019

  2. You have free access to this content
    The cost-effectiveness and budget impact of competing therapies in hepatic encephalopathy – a decision analysis

    Alimentary Pharmacology & Therapeutics

    Volume 26, Issue 8, October 2007, Pages: 1147–1161, E. HUANG, E. ESRAILIAN and B. M. R. SPIEGEL

    Version of Record online : 9 AUG 2007, DOI: 10.1111/j.1365-2036.2007.03464.x

  3. You have free access to this content
    Review article: potential mechanisms of action of rifaximin in the management of hepatic encephalopathy and other complications of cirrhosis

    Alimentary Pharmacology & Therapeutics

    Volume 43, Issue S1, January 2016, Pages: 11–26, J. S. Bajaj

    Version of Record online : 30 NOV 2015, DOI: 10.1111/apt.13435

  4. You have free access to this content
    Review article: the current pharmacological therapies for hepatic encephalopathy

    Alimentary Pharmacology & Therapeutics

    Volume 25, Issue s1, February 2007, Pages: 23–31, N. M. BASS

    Version of Record online : 23 JAN 2007, DOI: 10.1111/j.1746-6342.2006.03218.x

  5. Treatment Options for Hepatic Encephalopathy

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 30, Issue 5P2, May 2010, Pages: 16S–21S, Thomas D. Schiano

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.30.pt2.16S

  6. You have free access to this content
    Systematic review with network meta-analysis: the comparative effectiveness and safety of interventions in patients with overt hepatic encephalopathy

    Alimentary Pharmacology & Therapeutics

    Volume 41, Issue 7, April 2015, Pages: 624–635, G.-Q. Zhu, K.-Q. Shi, S. Huang, L.-R. Wang, Y.-Q. Lin, G.-Q. Huang, Y.-P. Chen, M. Braddock and M.-H. Zheng

    Version of Record online : 13 FEB 2015, DOI: 10.1111/apt.13122

  7. Comparison of once a day rifaximin to twice a day dosage in the prevention of recurrence of hepatic encephalopathy in patients with chronic liver disease

    Journal of Gastroenterology and Hepatology

    Volume 30, Issue 9, September 2015, Pages: 1420–1422, Nasir Khokhar, Muhammad Omar Qureshi, Shafiq Ahmad, Aiza Ahmad, Hamza Hassan Khan, Farzana Shafqat and Muhammad Salih

    Version of Record online : 27 JUL 2015, DOI: 10.1111/jgh.12970

  8. You have free access to this content
    Challenges of designing hepatic encephalopathy treatment trials

    Hepatology

    Volume 38, Issue 2, August 2003, Pages: 527–529, Madhusudhan R. Sanaka, Janus P. Ong and Kevin D. Mullen

    Version of Record online : 30 DEC 2003, DOI: 10.1002/hep.510380231

  9. You have free access to this content
    Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis

    Intervention Review

    The Cochrane Library

    Lise Lotte Gluud, Hendrik Vilstrup and Marsha Y Morgan

    Published Online : 6 MAY 2016, DOI: 10.1002/14651858.CD003044.pub4

  10. Effects of probiotics, lactitol and rifaximin on intestinal flora and fecal excretion of organic acids in cirrhotic patients

    Chinese Journal of Digestive Diseases

    Volume 4, Issue 1, April 2003, Pages: 13–18, P HOTTEN, F MAROTTA, Y NAITO, E MINELLI, A HELMY, J LIGHTHOUSE, H FUJI and E FESCE

    Version of Record online : 16 APR 2003, DOI: 10.1046/j.1443-9611.2003.00110.x

  11. You have free access to this content
    Systematic review with meta-analysis: the effects of rifaximin in hepatic encephalopathy

    Alimentary Pharmacology & Therapeutics

    Volume 40, Issue 2, July 2014, Pages: 123–132, N. Kimer, A. Krag, S. Møller, F. Bendtsen and L. L. Gluud

    Version of Record online : 21 MAY 2014, DOI: 10.1111/apt.12803

  12. Rifaximin vs. lactulose in treatment of minimal hepatic encephalopathy

    Liver International

    Volume 36, Issue 3, March 2016, Pages: 378–385, Sandeep S. Sidhu, Omesh Goyal, Richard A. Parker, Harsh Kishore and Ajit Sood

    Version of Record online : 17 AUG 2015, DOI: 10.1111/liv.12921

  13. You have free access to this content
    Gut instinct: Rifaximin for the prevention of hepatic encephalopathy

    Hepatology

    Volume 52, Issue 2, August 2010, Pages: 792–794, Asma Siddique and Kris Kowdley

    Version of Record online : 23 JUL 2010, DOI: 10.1002/hep.23822

  14. You have free access to this content
    Drug therapy: Rifaximin

    Hepatology

    Volume 52, Issue 4, October 2010, Pages: 1484–1488, Jasmohan S. Bajaj and Oliviero Riggio

    Version of Record online : 29 JUL 2010, DOI: 10.1002/hep.23866

  15. You have free access to this content
    Rifaximin treatment is associated with reduced risk of cirrhotic complications and prolonged overall survival in patients experiencing hepatic encephalopathy

    Alimentary Pharmacology & Therapeutics

    Volume 46, Issue 9, November 2017, Pages: 845–855, S. H. Kang, Y. B. Lee, J.-H. Lee, J. Y. Nam, Y. Chang, H. Cho, J.-J. Yoo, Y. Y. Cho, E. J. Cho, S. J. Yu, M. Y. Kim, Y. J. Kim, S. K. Baik and J.-H. Yoon

    Version of Record online : 24 AUG 2017, DOI: 10.1111/apt.14275

  16. You have free access to this content
    Review article: rifaximin, a minimally absorbed oral antibacterial, for the treatment of travellers’ diarrhoea

    Alimentary Pharmacology & Therapeutics

    Volume 31, Issue 11, June 2010, Pages: 1155–1164, P. LAYER and V. ANDRESEN

    Version of Record online : 11 MAR 2010, DOI: 10.1111/j.1365-2036.2010.04296.x

  17. You have full text access to this OnlineOpen article
    Prolonged remission from hepatic encephalopathy with rifaximin: results of a placebo crossover analysis

    Alimentary Pharmacology & Therapeutics

    Volume 41, Issue 1, January 2015, Pages: 39–45, J. S. Bajaj, A. C. Barrett, E. Bortey, C. Paterson and W. P. Forbes

    Version of Record online : 22 OCT 2014, DOI: 10.1111/apt.12993

  18. You have free access to this content
    Diagnosis and treatment of minimal hepatic encephalopathy to prevent motor vehicle accidents: A cost-effectiveness analysis

    Hepatology

    Volume 55, Issue 4, April 2012, Pages: 1164–1171, Jasmohan S. Bajaj, Steven D. Pinkerton, Arun J. Sanyal and Douglas M. Heuman

    Version of Record online : 27 MAR 2012, DOI: 10.1002/hep.25507

  19. The impact on hospital resource utilisation of treatment of hepatic encephalopathy with rifaximin-α

    Liver International

    Volume 36, Issue 9, September 2016, Pages: 1295–1303, James G. Orr, Craig J. Currie, Ellen Berni, Anurag Goel, Kieran J. Moriarty, Ashish Sinha, Fiona Gordon, Anne Dethier, John F. Dillon, Katie Clark, Paul Richardson, Paul Middleton, Vishal Patel, Debbie Shawcross, Helen Preedy, Richard J. Aspinall and Mark Hudson

    Version of Record online : 5 APR 2016, DOI: 10.1111/liv.13111

  20. Rifaximin antibiotic treatment for restless legs syndrome: a double-blind, placebo-controlled study

    Sleep and Biological Rhythms

    Volume 10, Issue 2, April 2012, Pages: 145–153, Leonard B WEINSTOCK and Suzie ZEISS

    Version of Record online : 4 MAR 2012, DOI: 10.1111/j.1479-8425.2012.00537.x